China Life stock: First-half value rose 33.70 percent for China Life stock
Published on 10/21/2026 at 16:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSInterim growth and dates
- China Life's new business value rose 33.70 percent to CNY 38.20 billion in the first half of 2026.
- First-half revenue reached CNY 434.60 billion, up 81.50 percent year over year.
- China Life stock costs EUR 2.63 at Lang & Schwarz on October 21, 2026 at 4:02 p.m. CEST.
China Life Insurance Company Limited (CNE1000002L3) generated CNY 38.20 billion in new business value in the first half of 2026, an increase of 33.70 percent from the same period a year earlier, according to FSM Global. The report also put first-half revenue at CNY 434.60 billion, up 81.50 percent year over year. China Life was trading at EUR 2.63 at Lang & Schwarz on October 21, 2026 at 4:02 p.m. CEST.
Revenue growth broadens the picture
The first-half figures show that China Life's improvement extended beyond earnings. Net profit reached CNY 134.50 billion, rising 228.60 percent year over year, while revenue growth exceeded the 36.50 percent forecast cited in the same FSM Global report.
New business value is a useful counterweight to investment-driven profit swings because it tracks the economic value expected from policies sold during the period. FSM Global reported that the insurer's total investment yield rose to 5.58 percent in the first half of 2026 from 3.29 percent a year earlier, while bancassurance premium income reached CNY 41.70 billion, up 12.40 percent.
Price position and valuation
The euro quotation gives German investors a direct market reference for the stock, while China Life's Hong Kong-listed line trades under ticker 2628 in HKD. The company's insurance operations cover life, health and accident products in China, and the business remains sensitive to investment returns because the insurer invests policyholder funds over long periods.
FSM Global also reported a first-half new business value margin of 35.00 percent and a 12-month forward price-to-earnings ratio of 4.70. Its report noted that China Life's earnings remain closely linked to investment performance, making reinvestment income an important variable for the next reporting period.
October 29 results date
MarketScreener lists October 29, 2026 as the date for China Life's third-quarter earnings release. That date gives investors the next scheduled checkpoint after the strong first-half comparison, particularly for investment income and new business value.
What the next report can clarify
The first-half revenue increase of 81.50 percent was more than twice the 36.50 percent forecast cited by FSM Global, creating a clear numerical benchmark for the third quarter. The next report can show whether operating growth continues alongside the unusually strong profit contribution from investment returns.
China Life stock stays at EUR 2.63
China Life was trading at EUR 2.63 at Lang & Schwarz on October 21, 2026 at 4:02 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of China Life stock.
China Life at a glance
- Company: China Life Insurance Company Limited
- ISIN: CNE1000002L3
- Ticker: 2628
- Primary exchange: Hong Kong Stock Exchange
- Price Lang & Schwarz (as of October 21, 2026, 4:02 p.m. CEST): EUR 2.63
- Sector / Industry: Life and health insurance
Market context: Latest market reports.
